Found 1465 results for "cancer"
One of the most stubborn challenges in oncology is that tumors engineer their own survival environment — starving themselves of oxygen while simultaneously rew…
One of the central ambitions in cancer immunotherapy is sustaining the killing power of CD8+ T cells long enough to defeat tumors and chronic infections. A rec…
Pancreatic cancer kills the vast majority of those diagnosed because it is almost never caught early — but what if the immune system could be primed years befo…
For decades, oncologists have known that some tumors appear to generate their own immune fortresses — organized lymphoid structures that can mount sustained at…
Understanding why leukemia so reliably outsmarts the immune system is one of oncology's most consequential puzzles — and a comprehensive new review in Frontier…
A decades-old surgical assumption — that removing as many lymph nodes as possible improves colorectal cancer outcomes — is now facing a credible biological cha…
Cancer immunotherapy stands at an inflection point: while mRNA vaccine platforms have proven clinically viable, their real-world efficacy has been constrained…
For millions living with autoimmune and chronic inflammatory conditions, the central therapeutic dilemma has long been a brutal trade-off: suppress the immune…
Understanding how the lung repairs and renews itself has profound implications for millions living with chronic respiratory conditions or at elevated cancer ri…
For the decades-long quest to replace uncomfortable tethered endoscopy with something patients will actually tolerate, this research represents a meaningful le…
For decades, one of the most common molecular drivers in prostate cancer has sat beyond the reach of drug developers — not because it was unimportant, but beca…
Breast cancer outcomes are strongly tied to stage at detection, making screening disparities a life-or-death equity issue. Black African women in high-income c…
The boundary between oncology immunotherapy and neurodegenerative disease treatment may be narrowing in a clinically meaningful way. Checkpoint inhibitors — dr…
Precision in radiation therapy hinges on one painstaking step: manually drawing boundaries around tumors and healthy organs on hundreds of CT image slices. For…
The idea of using living organisms as precision cancer-fighting agents is no longer science fiction — it is becoming an increasingly sophisticated engineering…
Spending more does not always mean screening better — and for older women on Medicare, a decade of data reveals a troubling drift toward costlier imaging techn…
HPV vaccination rates remain stubbornly low in parts of the United States, and the COVID-19 pandemic accelerated hesitancy in ways that oncologists and public…
Metastatic castration-resistant prostate cancer carries one of oncology's bleakest prognoses, and the antibody-drug conjugate revolution that reshaped breast a…
For patients facing cancers that have exhausted standard treatment options — pancreatic adenocarcinoma, glioblastoma, castration-resistant prostate cancer — th…
A decade after the first FDA approval of CDK4/6 inhibitors, oncology stands at a meaningful inflection point — one where the foundational lessons from breast c…